Diabetic Nephropathy

References

Citations

  1. American Diabetes Association (2007). Standards of medical care in diabetes. Clinical Practice Recommendations 2007. Diabetes Care, 30(Suppl 1): S4–S41.

  2. American Diabetes Association (2004). Nephropathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S79–S83.

  3. Steele AW (2001). Kidney disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 429–465. Hamilton, ON: BC Decker.

  4. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2001). Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). Journal of Pediatrics, 139(6): 804–812.

  5. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002). Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA, 287(19): 2563–2569.

  6. Van Dam RM, et al. (2002). Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Annals of Internal Medicine, 136(3): 201–209.

  7. ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001). Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Annals of Internal Medicine, 134(5): 370–379.

  8. Gerstein HC, et al. (2000). Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy. Lancet, 355(9200): 253–259.

  9. American Diabetes Association (2004). Preconception care of women with diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S76–S78.

Other Works Consulted

  • American Diabetes Association (2005). Diabetes complications and prevention. In American Diabetes Association Complete Guide to Diabetes, 4th ed. pp. 320–324. Alexandria, VA: American Diabetes Association.

  • Bakris GL (2003). The evolution of treatment guidelines for diabetic nephropathy. Postgraduate Medicine, 113(5): 35–50.


Go to previous sectionGo to previous sectionGo to top of pageGo to top of pageGo to next sectionGo to next section

Author: Robin Parks, MSLast Updated: January 17, 2007
Medical Review: Caroline S. Rhoads, MD - Internal Medicine
Kathleen Romito, MD - Family Medicine
D.C. Mendelssohn, MD, FRCPC - Nephrology

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise

Topic Contents
 Topic Overview
 Health Tools Click here to view Health Tools.
 Symptoms
 Exams and Tests
 Treatment Overview
 Home Treatment
 Other Places To Get Help
 Related Information
Arrow PointerReferences
 Credits